"Ranitidine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers.
| Descriptor ID |
D011899
|
| MeSH Number(s) |
D03.383.312.750
|
| Concept/Terms |
Ranitidine- Ranitidine
- Ranitidin
- N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine
|
Below are MeSH descriptors whose meaning is more general than "Ranitidine".
Below are MeSH descriptors whose meaning is more specific than "Ranitidine".
This graph shows the total number of publications written about "Ranitidine" by people in this website by year, and whether "Ranitidine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 3 | 3 |
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 2 | 3 |
| 2002 | 0 | 2 | 2 |
| 2005 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ranitidine" by people in Profiles.
-
Management of a neonate with diffuse cutaneous mastocytosis: Case report and literature review. Pediatr Dermatol. 2019 Jul; 36(4):486-489.
-
Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori. Aliment Pharmacol Ther. 2005 Jan 15; 21(2):165-8.
-
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther. 2002 Feb; 16(2):167-80.
-
Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users. Helicobacter. 2002 Feb; 7(1):1-8.
-
Gastric antisecretory and antiulcer activity of oxytocin in rats and guinea pigs. Life Sci. 2001 Nov 21; 70(1):17-24.
-
Maximal acid reflux control for Barrett's oesophagus: feasible and effective. Aliment Pharmacol Ther. 2001 Apr; 15(4):519-24.
-
Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs. Am J Med. 2001 Jan 08; 110(1A):58S-61S.
-
The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy. Am J Surg. 2000 Jun; 179(6):446-52.
-
Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection. Aliment Pharmacol Ther. 1999 Feb; 13(2):169-72.
-
Parietal cell protrusions (PCP) in gastric ulcer disease. Hum Pathol. 1998 Jul; 29(7):765-6.